2024-09 |
Efficacy of single-dose evolocumab injection in early-phase acute myocardial infarction: a retrospective single-center study |
Korean Journal of Internal Medicine
|
2024-08 |
Intravascular ultrasound-guided drug-coated balloon angioplasty for femoropopliteal artery disease: a clinical trial |
European Heart Journal
|
2024-07 |
Treat-to-target or high-intensity statin treatment in older adults with coronary artery disease: a post hoc analysis of the LODESTAR trial |
Age and Ageing
|
2024-05 |
Association of Age- and Body Mass Index-Stratified High On-Treatment Platelet Reactivity With Coronary Intervention Outcomes in East Asian Patients |
Journal of the American Heart Association
|
2024-05 |
Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention for acute myocardial infarction with cardiogenic shock |
Scientific Reports
|
2024-05 |
Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention for acute myocardial infarction with cardiogenic shock |
Scientific Reports
|
2024-05 |
Simultaneous Viability Assessment and Invasive Coronary Angiography Using a Therapeutic CT System in Chronic Myocardial Infarction Patients |
Yonsei Medical Journal
|
2024-04 |
P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy After Deployment of a Drug-Eluting Stent: The SHARE Randomized Clinical Trial |
Jama Network Open
|
2024-03 |
Moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with metabolic syndrome and atherosclerotic cardiovascular disease: A post-hoc analysis of the RACING trial |
Diabetes, Obesity and Metabolism
|
2024-03 |
P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy After Deployment of a Drug-Eluting Stent: The SHARE Randomized Clinical Trial |
Jama Network Open
|
2024-03 |
Identification of acute myocardial infarction and stroke events using the National Health Insurance Service database in Korea |
Epidemiology and health
|
2024-03 |
Moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with metabolic syndrome and atherosclerotic cardiovascular disease: A post-hoc analysis of the RACING trial |
Diabetes, Obesity and Metabolism
|
2024-02 |
Comparison of Intracardiac Echocardiography Versus Transesophageal Echocardiography for Guidance During Transcatheter Aortic Valve Replacement |
Korean Circulation Journal
|
2024-02 |
Stopping Aspirin Within 1 Month After Stenting for Ticagrelor Monotherapy in Acute Coronary Syndrome: The T-PASS Randomized Noninferiority Trial |
Circulation
|
2023-12 |
Incidence and case fatality of acute myocardial infarction in Korea, 2011-2020 |
Epidemiology and health
|
2023-12 |
Moderate-intensity statin plus ezetimibe vs high-intensity statin according to baseline LDL-C in the treatment of atherosclerotic cardiovascular disease: A post-hoc analysis of the RACING randomized trial |
Atherosclerosis
|
2023-12 |
Association Between Body Mass Index and Clinical Outcomes According to Diabetes in Patients Who Underwent Percutaneous Coronary Intervention |
Korean Circulation Journal
|
2023-11 |
Effect of moderate-intensity statin with ezetimibe combination vs. high-intensity statin therapy according to sex in patients with atherosclerosis |
Scientific Reports
|
2023-10 |
Rosuvastatin versus atorvastatin treatment in adults with coronary artery disease: secondary analysis of the randomised LODESTAR trial |
BMJ-British Medical Journal
|
2023-10 |
Perioperative Antiplatelet Strategy in Patients Undergoing Noncardiac Surgery Within One Year After Percutaneous Coronary Intervention |
American Journal of Medicine
|
2023-10 |
Impact of Intravascular Ultrasound-Guided Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction and Chronic Kidney Disease
|
Circulation Journal
|
2023-10 |
Efficacy of Percutaneous Coronary Intervention With Synergy Stents in Patients Aged ≥75 Years: 1-Year Clinical Outcomes from the Synergy Elderly Registry |
American Journal of Cardiology
|
2023-09 |
Treat-to-target versus high-intensity statin treatment in patients with or without diabetes mellitus: a pre-specified analysis from the LODESTAR trial |
EClinicalMedicine
|
2023-09 |
Moderate-Intensity Statin With Ezetimibe Combination Therapy vs High-Intensity Statin Monotherapy in Patients at Very High Risk of Atherosclerotic Cardiovascular Disease: A Post Hoc Analysis From the RACING Randomized Clinical Trial |
JAMA cardiology
|
2023-08 |
Clinical implication of ticagrelor monotherapy in patients with small vessel coronary artery disease: results from the TICO randomized trial |
Frontiers in Cardiovascular Medicine
|
2023-08 |
Impact of intravascular ultrasound in acute myocardial infarction patients at high ischemic risk |
REVISTA ESPANOLA DE CARDIOLOGIA
|
2023-08 |
Combination Lipid-Lowering Therapy in Patients Undergoing Percutaneous Coronary Intervention |
Journal of the American College of Cardiology
|
2023-07 |
Device Effectiveness for Femoropopliteal Artery Disease Treatment: An Analysis of K-VIS ELLA Registry |
JACC: Cardiovascular Interventions
|
2023-07 |
A Randomized, Multicenter, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a Quadruple Combination of Amlodipine, Losartan, Rosuvastatin, and Ezetimibe in Patients with Concomitant Essential Hypertension and Dyslipidemia |
American Journal of Cardiovascular Drugs
|
2023-06 |
Sex Differences in Outcomes of Ticagrelor Therapy With or Without Aspirin After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: A Post Hoc Secondary Analysis of the TICO Randomized Clinical Trial |
Arteriosclerosis, Thrombosis, and Vascular Biology
|
2023-05 |
Sex Differences in Midterm Prognostic Implications of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents in East Asian Patients: Results From the PTRG-DES (Platelet Function and Genotype-Related Long-Term Prognosis in Drug-Eluting Stent-Treated Patients With Coronary Artery Disease) Consortium |
Journal of the American Heart Association
|
2023-04 |
Combination Moderate-Intensity Statin and Ezetimibe Therapy for Elderly Patients With Atherosclerosis |
Journal of the American College of Cardiology
|
2023-04 |
Treat-to-Target or High-Intensity Statin in Patients with Coronary Artery Disease: A Randomized Clinical Trial |
JAMA
|
2023-04 |
Dual antiplatelet therapy after percutaneous coronary intervention for left main coronary artery disease |
REVISTA ESPANOLA DE CARDIOLOGIA
|
2023-04 |
Clinical Impact of CYP2C19 Genotype on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention |
JACC: Cardiovascular Interventions
|
2023-04 |
Efficacy and safety of moderate-intensity statin with ezetimibe combination therapy in patients after percutaneous coronary intervention: a post-hoc analysis of the RACING trial |
EClinicalMedicine
|
2023-03 |
Body mass index affecting ticagrelor monotherapy vs. ticagrelor with aspirin in patients with acute coronary syndrome: A pre-specified sub-analysis of the TICO randomized trial |
Frontiers in Cardiovascular Medicine
|
2023-03 |
Moderate-intensity statin with ezetimibe vs. high-intensity statin in patients with diabetes and atherosclerotic cardiovascular disease in the RACING trial |
European Heart Journal
|
2023-03 |
Stent expansion evaluated by optical coherence tomography and subsequent outcomes |
Scientific Reports
|
2023-01 |
Assessment of fractional flow reserve in intermediate coronary stenosis using optical coherence tomography-based machine learning |
Frontiers in Cardiovascular Medicine
|
2022-12 |
Sex difference after acute myocardial infarction patients with a history of current smoking and long-term clinical outcomes: Results of KAMIR Registry |
CARDIOLOGY JOURNAL
|
2022-11 |
Platelet Reactivity and Clinical Outcomes After Drug-Eluting Stent Implantation: Results From the PTRG-DES Consortium. |
JACC: Cardiovascular Interventions
|
2022-10 |
A Multicenter, Randomized, Double-blind, Active-controlled, Factorial Design, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of Pitavastatin and Ezetimibe Versus Monotherapy of Pitavastatin in Patients With Primary Hypercholesterolemia |
CLINICAL THERAPEUTICS
|
2022-10 |
Long coverage with drug-eluting stents is superior to spot coverage for long femoropopliteal artery disease: PARADE II study |
Frontiers in Cardiovascular Medicine
|
2022-09 |
Effects of high-intensity statin combined with telmisartan versus amlodipine on glucose metabolism in hypertensive atherosclerotic cardiovascular disease patients with impaired fasting glucose: A randomized multicenter trial |
Medicine
|
2022-09 |
Effect of FIXed-dose combination of ARb and statin on adherence and risk factor control: The randomized FIXAR study |
CARDIOLOGY JOURNAL
|
2022-08 |
Impact of one-month DAPT followed by aspirin monotherapy in patients undergoing percutaneous coronary intervention according to clinical presentation: a post hoc analysis of the randomised One-Month DAPT trial |
EUROINTERVENTION
|
2022-08 |
Prolonged dual antiplatelet therapy after drug-eluting stent implantation in patients with diabetes mellitus: A nationwide retrospective cohort study |
FRONTIERS IN CARDIOVASCULAR MEDICINE
|
2022-07 |
ST-elevation versus non-ST-elevation myocardial infarction after combined use of statin with renin-angiotensin system inhibitor: Data from the Korea Acute Myocardial Infarction Registry |
Cardiology Journal
|
2022-07 |
Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial. |
LANCET
|
2022-07 |
Procedural Characteristics of Intravascular Ultrasound–Guided Percutaneous Coronary Intervention and Their Clinical Implications |
JOURNAL OF THE AMERICAN HEART ASSOCIATION
|
2022-07 |
Benefit and risk of prolonged dual antiplatelet therapy after drug-eluting stent implantation in patients with chronic kidney disease: A nationwide cohort study |
Atherosclerosis
|
2022-06 |
Computational Fractional Flow Reserve From Coronary Computed Tomography Angiography-Optical Coherence Tomography Fusion Images in Assessing Functionally Significant Coronary Stenosis |
FRONTIERS IN CARDIOVASCULAR MEDICINE
|
2022-05 |
Platelet Function and Genotype after DES Implantation in East Asian Patients: Rationale and Characteristics of the PTRG-DES Consortium |
Yonsei Medical Journal
|
2022-05 |
Impact of New-Onset Persistent Left Bundle Branch Block on Reverse Cardiac Remodeling and Clinical Outcomes After Transcatheter Aortic Valve Replacement. |
Frontiers in Cardiovascular Medicine
|
2022-05 |
Safety and Efficacy of Contemporary Drug-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction and a High Ischemic Risk |
Frontiers in Cardiovascular Medicine
|
2022-05 |
Long-term beta-blocker therapy in patients with stable coronary artery disease after percutaneous coronary intervention |
Frontiers in Cardiovascular Medicine
|
2022-04 |
Ticagrelor Monotherapy After 3-Month Dual Antiplatelet Therapy in Acute Coronary Syndrome by High Bleeding Risk: The Subanalysis From the TICO Trial |
KOREAN CIRCULATION JOURNAL
|
2022-04 |
Long-Term Clinical Outcomes Between Biodegradable and Durable Polymer Drug-Eluting Stents: A Nationwide Cohort Study |
Frontiers in Cardiovascular Medicine
|
2022-03 |
Outcome of early versus delayed invasive strategy in patients with non-ST-segment elevation myocardial infarction and chronic kidney disease not on dialysis |
Atherosclerosis
|
2022-03 |
Role of Intravascular Ultrasound-Guided Percutaneous Coronary Intervention in Optimizing Outcomes in Acute Myocardial Infarction |
JOURNAL OF THE AMERICAN HEART ASSOCIATION
|
2022-02 |
Clinical outcomes of Atherectomy plus drug-coated balloon versus drug-coated balloon alone in the treatment of femoropopliteal artery disease |
Korean Circulation Journal
|
2022-02 |
Effect of Wire Jailing at Side Branch in 1-Stent Strategy for Coronary Bifurcation Lesions. |
JACC-CARDIOVASCULAR INTERVENTIONS
|
2022-01 |
Clinical Implications of Poststent Optical Coherence Tomographic Findings: Severe Malapposition and Cardiac Events. |
JACC: Cardiovascular Imaging
|
2022-01 |
Effect of ticagrelor monotherapy on mortality after percutaneous coronary intervention: a systematic review and meta-analysis of randomized trials including 26 143 patients. |
European heart journal - Cardiovascular pharmacotherapy
|
2022-01 |
Is Routine Postdilation During Angiography-Guided Stent Implantation as Good as Intravascular Ultrasound Guidance?: An Analysis Using Data From IVUS-XPL and ULTIMATE |
Circulation. Cardiovascular interventions
|
2022-01 |
Improved 3-Year Cardiac Survival After IVUS–Guided Long DES Implantation: A Patient-Level Analysis From 2 Randomized Trials |
JACC-CARDIOVASCULAR INTERVENTIONS
|
2022-01 |
Ticagrelor vs. Clopidogrel in AcuteCoronary Syndrome Patients WithChronic Kidney Disease AfterNew-Generation Drug-Eluting StentImplantation |
Frontiers in Cardiovascular Medicine
|
2021-12 |
ST-segment elevation versus non-ST-segment elevation myocardial infarction in current smokers after newer-generation drug-eluting stent implantation |
MEDICINE
|
2021-12 |
Skin Perfusion Pressure Predicts Early Wound Healing After Endovascular Therapy in Chronic Limb Threatening Ischaemia. |
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
|
2021-12 |
Age-Dependent Effect of Ticagrelor Monotherapy Versus Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events: A Post Hoc Analysis of the TICO Randomized Trial. |
JOURNAL OF THE AMERICAN HEART ASSOCIATION
|
2021-11 |
Comparison of two-year clinical outcomes according to glycemic status and renal function in patients with acute myocardial infarction following implantation of new-generation drug-eluting stents |
JOURNAL OF DIABETES AND ITS COMPLICATIONS
|
2021-11 |
Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic Risk |
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
|
2021-11 |
Outcomes between prediabetes and type 2 diabetes mellitus in older adults with acute myocardial infarction in the era of newer-generation drug-eluting stents: a retrospective observational study |
BMC GERIATRICS
|
2021-11 |
Temporal Trends of Antithrombotic Therapy in Patients With Acute Myocardial Infarction and Atrial Fibrillation: Insight From the KAMIR-NIH Registry |
Frontiers in Cardiovascular Medicine
|
2021-11 |
Clinical Impact of Single and Dual Antiplatelet Therapy Beyond 12 Months on Ischemic Risk in Patients With Acute Myocardial Infarction |
Frontiers in Cardiovascular Medicine
|